Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects
Abdallah Turky, Ashraf H. Bayoumi, Adel Ghiaty, et al.
Bioorganic Chemistry (2020) Vol. 101, pp. 104019-104019
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity
Mohamed H. El‐Shershaby, Adel Ghiaty, Ashraf H. Bayoumi, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 42, pp. 116266-116266
Closed Access | Times Cited: 64
The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis and in silico mechanistic studies as dual DNA gyrase and DHFR inhibitors
Mohamed H. El‐Shershaby, Kamal M. El‐Gamal, Ashraf H. Bayoumi, et al.
New Journal of Chemistry (2021) Vol. 45, Iss. 31, pp. 13986-14004
Closed Access | Times Cited: 56
Pharmacophore‐linked pyrazolo[3,4‐d]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies
Ahmed A. Abdel Gaber, Ahmed El-morsy, Farag F. Sherbiny, et al.
Archiv der Pharmazie (2021)
Closed Access | Times Cited: 55
Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105762-105762
Closed Access | Times Cited: 51
Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations
Fathalla Khedr, Mohamed‐Kamal Ibrahim, Ibrahim H. Eissa, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 11
Closed Access | Times Cited: 48
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro , and in silico mechanistic investigations
Arafa Musa, Saleh Ihmaid, David L. Hughes, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 12411-12425
Open Access | Times Cited: 19
Recent Advances on Small-Molecule Bromodomain-Containing Histone Acetyltransferase Inhibitors
Mingxia Liu, Kaiyao Zhang, Qinjue Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1678-1699
Closed Access | Times Cited: 18
Exploring the cytotoxic effect and CDK-9 inhibition potential of novel sulfaguanidine-based azopyrazolidine-3,5-diones and 3,5-diaminoazopyrazoles
Ebtehal M. Husseiny, Hamada S. Abulkhair, Nehad M. El‐Dydamony, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106397-106397
Closed Access | Times Cited: 18
Androgen receptor cofactors: A potential role in understanding prostate cancer
Xiang Li, Haojun Xiong, Xingzhu Mou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116338-116338
Open Access | Times Cited: 6
Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors
Mona S. El‐Zoghbi, Amr K.A. Bass, Gamal El‐Din A. Abuo‐Rahma, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 7, pp. 601-622
Open Access | Times Cited: 5
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies
Abdallah Turky, Ashraf H. Bayoumi, Farag F. Sherbiny, et al.
Molecular Diversity (2020) Vol. 25, Iss. 1, pp. 403-420
Closed Access | Times Cited: 43
Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives
Mohamed H. El‐Shershaby, Kamal M. El‐Gamal, Ashraf H. Bayoumi, et al.
Archiv der Pharmazie (2020) Vol. 354, Iss. 2
Closed Access | Times Cited: 39
Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors
Khaled El‐Adl, Helmy Sakr, Sanadelaslam S. A. El‐Hddad, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 7
Closed Access | Times Cited: 38
1,2,4-Triazolo[4,3-c]quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity
Mohamed H. El‐Shershaby, Adel Ghiaty, Ashraf H. Bayoumi, et al.
New Journal of Chemistry (2021) Vol. 45, Iss. 25, pp. 11136-11152
Closed Access | Times Cited: 37
In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors
Hamada S. Abulkhair, Salwa Elmeligie, Adel Ghiaty, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 5
Closed Access | Times Cited: 35
Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking study
Abdelrahman Hamdi, Walaa M. El-Husseiny, Dina I. A. Othman, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114827-114827
Closed Access | Times Cited: 22
A novel class of phenylpyrazolone-sulphonamides rigid synthetic anticancer molecules selectively inhibit the isoform IX of carbonic anhydrases guided by molecular docking and orbital analyses
Maan T. Khayat, Hany E. A. Ahmed, Abdelsattar M. Omar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 15243-15261
Closed Access | Times Cited: 14
N‐Substituted‐4‐phenylphthalazin‐1‐amine‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studies
Khaled El‐Adl, Mohamed‐Kamal Ibrahim, Fathalla Khedr, et al.
Archiv der Pharmazie (2020) Vol. 354, Iss. 3
Closed Access | Times Cited: 34
New pyrazole-tetrazole hybrid compounds as potent α-amylase and non-enzymatic glycation inhibitors
Ahlam Oulous, Nour Elhouda Daoudi, Tarik Harit, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 69, pp. 128785-128785
Closed Access | Times Cited: 18
New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerization
Hend A. A. Ezelarab, Taha F. S. Ali, Samar H. Abbas, et al.
Molecular Diversity (2023) Vol. 28, Iss. 2, pp. 563-580
Open Access | Times Cited: 10
Exploration of the VEGFR-2 inhibition activity of phthalazine derivatives: design, synthesis, cytotoxicity, ADMET, molecular docking and dynamic simulation
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 30, pp. 21668-21681
Open Access | Times Cited: 3
Synthetic and medicinal chemistry of phthalazines: Recent developments, opportunities and challenges
Sumera Zaib, Imtiaz Khan
Bioorganic Chemistry (2020) Vol. 105, pp. 104425-104425
Closed Access | Times Cited: 31
Novel 1,2,4‐triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies
Abdallah Turky, Farag F. Sherbiny, Ashraf H. Bayoumi, et al.
Archiv der Pharmazie (2020) Vol. 353, Iss. 12
Closed Access | Times Cited: 30
Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors
Amr K.A. Bass, El-Shimaa M. Nageeb, Mona S. El‐Zoghbi, et al.
Bioorganic Chemistry (2021) Vol. 119, pp. 105564-105564
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top